Lunit Attends as Associate Member at Davos Forum... Expanding Global Network Following JPMHC

Medical AI company Lunit announced on the 23rd that Seobum Seok, CEO of Lunit, attended the 'World Economic Forum (WEF·Davos Forum)' held in Davos, Switzerland from the 15th to the 19th, as the first representative from a domestic small and medium-sized enterprise (SME) to obtain associate membership, marking his second consecutive year attending the Davos Forum.

Seo Beom-seok, CEO of Lunit, attending the 2024 World Economic Forum (WEF). [Photo by Lunit]

The Davos Forum is an annual event where global political and economic leaders gather to discuss international issues. Celebrating its 54th year this year, the forum was held under the theme of 'Rebuilding Trust,' with over 2,800 participants including 60 heads of state. In November last year, Lunit was promoted to associate membership, becoming the first medical AI company among over 1,000 member companies within the Davos Forum, including domestic SMEs, thereby securing a permanent opportunity to participate in the forum.

Following his first participation last year, CEO Seobum Seok strengthened his network at this year’s Davos Forum by engaging with CEOs of major global pharmaceutical companies and held expanded collaboration discussions regarding ongoing partnerships with representatives of global medical device partners. Through exchanges with government officials, key corporate representatives, and NGO leaders from various countries, he explored opportunities for AI application in healthcare sectors of developing countries. Additionally, he met with over 300 individuals from various AI and data companies, further refining the direction of the AI platform developed by Lunit.

Prior to the Davos Forum, from the 8th to the 11th, CEO Seobum Seok also attended the 'JP Morgan Healthcare Conference (JPMHC),' the world’s largest pharmaceutical and biotech investment event held in San Francisco, California, USA. He held partnering meetings with over 30 global pharmaceutical companies and investors to discuss mutual cooperation strategies. Notably, he received investment and acquisition proposals from several companies and investors, reflecting the changed status since the acquisition of Volpara Health Technology in December last year. Some of the companies contacted through this JPMHC are expected to discuss mergers and acquisitions (M&A) or investment plans within this year.

Seobum Seok, CEO of Lunit, said, "As we welcome the new year, we are actively participating in top-tier annual global events held in the US and Europe, such as the Davos Forum and JPMHC, solidifying our global network." He added, "This global approach will serve as a catalyst to invigorate Lunit’s overseas business initiatives planned for this year."

This content was produced with the assistance of AI translation services.